Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding a...(p...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months
Date:10/8/2008
p>
'/>"/>
| SOURCE Vical Incorporated Copyright©2008 PR Newswire. All rights reserved |
Related medicine technology :
1. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
2. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
3. Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
4. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
5. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
6. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
7. Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant
8. New Study Shows Listeria Vaccine for Cervical Cancer Found Safe
9. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
10. Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial
11. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
Post Your Comments:
(Date:12/4/2009)... 4 AstraZeneca (NYSE: AZN ) today ... has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release ... with Major Depressive Disorder (MDD). SEROQUEL XR is the ... to treat both major depressive disorder as adjunctive therapy ...
(Date:12/3/2009)... 3 A genetic variation that may indicate a ... if exposed to certain pharmaceutical therapies or chemicals is ... leader Quest Diagnostics (NYSE: DGX ) will ... Annual Meeting and Exposition, December 5-8, 2009, in New ...
(Date:12/3/2009)... Delaware-based company specializing in pharmaceutical risk management and optimal ... Dec. 9, on the FDA,s draft guidance on REMS ... implications for REMS lifecycle management. Dr. Gary Slatko, ... REMS and risk management programs, will lead the one-hour ...
Breaking Medicine Technology:US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Micromet to Present at The 8th Annual BIO Investor Forum Conference on October 29 2009 5652 1Micromet to Present at The 8th Annual BIO Investor Forum Conference on October 29 2009 5652 2Internet fuels virtual subculture for sex trade study finds 59921 1Internet fuels virtual subculture for sex trade study finds 59921 2Alzheimers lesions found in the retina 59918 1Alzheimers lesions found in the retina 59918 2[0] US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder[0] Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition[0] Webinar to Explore FDA Draft REMS Guidance and Its Implications for Lifecycle Management
... BOSTON, April 9, 2008 New devices and ... National Institutes,of Health (NIH) National Heart, Lung, and ... discussed at the International Society,for Heart and Lung ... meeting is ongoing this week at the Boston,Marriott ...
... PharmAthene,Inc. (Amex: PIP ) a ... of medical countermeasures against chemical and,biological threats, ... of Jerusalem, one of PharmAthene,s collaboration partners, ... (rBChE), a non-pegylated form of Protexia(R), may,have ...
Other Medicine Technology:New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting 2PharmAthene's Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimer's Disease 2PharmAthene's Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimer's Disease 3PharmAthene's Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimer's Disease 4PharmAthene's Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimer's Disease 5(Date:12/5/2009)... debunks the ,something,s wrong with being single, myth , , SATURDAY, ... who pass their 40th birthday without ever tying the knot, ... woes than married folks. And, um, isn,t there something wrong ... fast. , A new study looking at psychological measures shows ...
(Date:12/4/2009)... Systems (NYSE: VAR ) announced today that its ... of Stockholders for February 11, 2010 with a record date ... the Crowne Plaza Cabana Hotel, 4290 El Camino Real, Palo ... be webcast by Thomson Financial and can be accessed at ...
(Date:12/4/2009)... The American Association of Homes and Services for the Aging ... Living and Supportive Services (CLASS) provisions remain in the final ... providing support to elders, people with disabilities and their caregivers. ... care reform bill that will make it affordable to care ...
(Date:12/4/2009)... While Congress debates whether health care reform ... point to 45 hospitals that lead through example ... nation while attaining the highest levels of efficiency. ... have been named 2009 Leapfrog Top Hospitals, based ...
(Date:12/4/2009)... Western Reserve University researchers, from the School of Medicine,s ... which products of lipid peroxidation and some drugs of ... identified by a combination of metabolomics and mass isotopomer ... of action of the drug of abuse gamma-hydroxybutyrate, also ...
Breaking Medicine News(10 mins):Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2[0] Never Married, Over 40, Well-Adjusted[0] Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto[0] Statement from AAHSA CEO Larry Minnix on the Failure of the Thune Amendment[0] The Leapfrog Group Releases Its 2009 Top Hospitals List[0] Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week'
... the pharmaceutical Antifoam (Simethicone) business from Bluestar Silicones. , ... ... -- NuSil Technology ( http://www.nusil.com ), a leading formulator and ... announced a definitive agreement to acquire the pharmaceutical Antifoam (Simethicone) ...
... Sleep apnea has long been known to be associated with ... issue of Diabetes Care finds that the disorder ... nearly 87 percent of participants reported symptoms, but were ... doesn,t just mean their sleep is disrupted; existing research shows ...
... following is a statement of Matthew L. Myers, ... http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ) The Campaign for Tobacco-Free ... his leadership role in Senate committee approval of ... Administration (FDA) regulatory authority over tobacco products, including ...
... Smart Balance, Inc. (Nasdaq: SMBL ) today held ... and CEO Stephen Hughes spoke to stockholders about the Company,s ... past year, consumers have found Smart Balance,s brand proposition compelling ... category of spreads," Hughes said. "We are excited as ...
... communities in outstate Minnesota MINNEAPOLIS, May 20 ... regional grants dedicated to reducing tobacco,s harm through ... grants will provide resources to communities outside the ... our continuing commitment to reducing tobacco,s harm and ...
... the Archdiocese of Boston may soon refer women ... Centene Corp. and archdiocese-run Caritas Christi Health Care.(Logo: ... over the impact of nationalized health care on ... to ethically compromise with a potential federal health ...
Other Medicine News:Health News:NuSil Technology Acquires Pharmaceutical Antifoam (Simethicone) Business from Bluestar Silicones 2Health News:NuSil Technology Acquires Pharmaceutical Antifoam (Simethicone) Business from Bluestar Silicones 3Health News:More than a bad night's sleep 2Health News:Sen. Tom Harkin Votes to Protect America's Kids From Tobacco 2Health News:Sen. Tom Harkin Votes to Protect America's Kids From Tobacco 3Health News:ClearWay Minnesota(SM) Board Approves Four Regional Grants 2Health News:ALL: Boston Archdiocese Reportedly on Track for Abortion Referring Venture 2NuSil Technology Acquires Pharmaceutical Antifoam (Simethicone) Business from Bluestar Silicones More than a bad night's sleepSen. Tom Harkin Votes to Protect America's Kids From TobaccoSmart Balance Holds Annual Stockholders MeetingClearWay Minnesota(SM) Board Approves Four Regional GrantsALL: Boston Archdiocese Reportedly on Track for Abortion Referring Venture
Adhesive discs sold on rolls of 100, 250, or 1000 each. Manufactured from non-latex medical grade adhesives & material. One size fits all chest pieces....
For accurately monitoring core temperature and heart and breath sounds....
... enables hospitals to standardize ... to a single temperature ... monitoring disposale probes and ... in their manufacture and ...
... Level 1 enables ... multiparameter patient monitors to ... series. Our temperature monitoring ... cables are superior in ...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |